The company will use net proceeds from the IPO for meeting working capital requirements, repayment of loans and the general corporate purposes For the full story, visit the source.
Business
Q-Line Biotech to raise ₹214 cr via IPO on NSE Emerge
The company will use net proceeds from the IPO for meeting working capital requirements, repayment of loans and the general corporate purposes
By BL Mumbai Bureau· BusinessLine· 9 days ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine